- Report
- November 2023
- 149 Pages
Global
From €2402EUR$2,499USD£2,060GBP
- Report
- November 2023
- 147 Pages
Global
From €2402EUR$2,499USD£2,060GBP
- Report
- October 2023
- 142 Pages
Global
From €2402EUR$2,499USD£2,060GBP
- Report
- September 2023
- 146 Pages
Global
From €2402EUR$2,499USD£2,060GBP
- Report
- June 2023
- 143 Pages
Global
From €2402EUR$2,499USD£2,060GBP
- Report
- May 2023
- 143 Pages
Global
From €2402EUR$2,499USD£2,060GBP
- Report
- January 2024
- 200 Pages
Global
From €4806EUR$5,000USD£4,121GBP
- Report
- March 2024
- 141 Pages
Global
From €3748EUR$3,899USD£3,214GBP
- Report
- June 2023
- 138 Pages
Global
From €2402EUR$2,499USD£2,060GBP
- Report
- May 2024
- 194 Pages
Global
From €5238EUR$5,450USD£4,492GBP
- Report
- September 2023
- 196 Pages
Global
From €3061EUR$3,185USD£2,625GBP
€4373EUR$4,550USD£3,750GBP
- Report
- February 2024
- 120 Pages
Global
From €4565EUR$4,750USD£3,915GBP
- Report
- April 2024
- 30 Pages
Global
From €2643EUR$2,750USD£2,267GBP
- Report
- April 2024
- 30 Pages
Global
From €2643EUR$2,750USD£2,267GBP
- Report
- April 2024
- 30 Pages
Global
From €2643EUR$2,750USD£2,267GBP
- Report
- February 2024
- 30 Pages
Global
€3412EUR$3,550USD£2,926GBP
- Report
- February 2024
- 30 Pages
Global
€3412EUR$3,550USD£2,926GBP
- Report
- January 2024
- 66 Pages
Global
From €3989EUR$4,150USD£3,421GBP
- Report
- February 2024
- 185 Pages
Global
From €4710EUR$4,900USD£4,039GBP
- Report
- January 2024
- 185 Pages
Global
From €4710EUR$4,900USD£4,039GBP
The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists.
The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more